Research study Program year 2024 Source: CMS Open Payments

Phase I/II FIH Monotherapy/Combination

Research payments

$319,000

6 payments

Through program year 2024, $319,000 in research payments was reported against Phase I/II FIH Monotherapy/Combination, across 6 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by: E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$90,742	4
2023	Research	$228,258	2

Breakdown

Who paid Research payments · program years 2023–2024

E.R. Squibb & Sons, L.L.C. $319,000 6 payments

Who received the money Research payments · program years 2023–2024

Monter Cancer Center Organisation paid for research $179,446 1 payment
Hackensack University Medical Center Teaching hospital · NJ $48,813 1 payment
Yale University Organisation paid for research $31,015 1 payment
Eresearch Technology, Incorporated Organisation paid for research $27,062 1 payment
Wirb Organisation paid for research $19,567 1 payment
Yale-New Haven Hospital Teaching hospital · CT $13,097 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.